Treatment of Helicobacter pylori Infection in India
First-Line Treatment Recommendation
- The Indian medical community recommends bismuth quadruple therapy for 14 days as the first-line treatment for H. pylori infection, due to high rates of clarithromycin and metronidazole resistance, with an eradication rate of 80-90% 1, 2
- The regimen composition includes high-dose PPI twice daily + bismuth subsalicylate 262 mg (or bismuth subcitrate 120 mg) four times daily + metronidazole 500 mg three to four times daily + tetracycline 500 mg four times daily, which achieves high eradication rates even in the presence of metronidazole resistance 1, 2
- No bacterial resistance to bismuth has been described, and tetracycline resistance remains rare in India at 1-4% 3
Critical Optimization Factors
- The American Gastroenterological Association recommends using high-dose PPI twice daily, taken 30 minutes before meals, to increase cure rates by 8-12% 1, 4
- Higher metronidazole doses (1.5-2 g daily in divided doses) improve eradication rates even with resistant strains when combined with bismuth 1
Second-Line Treatment After First-Line Failure
- The European Helicobacter Study Group recommends levofloxacin-based triple therapy as the second-line option after bismuth quadruple therapy failure, with a regimen of high-dose PPI (esomeprazole or rabeprazole 40 mg) twice daily + amoxicillin 1000 mg twice daily + levofloxacin 500 mg once daily for 14 days 1, 4
- Levofloxacin resistance remains low in India (1-4%), making this an effective rescue option 3, 1
Confirmation of Eradication
- The American College of Gastroenterology recommends testing for eradication success using urea breath test or validated monoclonal stool antigen test at least 4 weeks after completion of therapy 3, 1
- Discontinue PPI at least 2 weeks before testing to avoid false-negative results 3, 1
- Never use serology to confirm eradication as antibodies persist long after successful treatment 1